A recent study demonstrated that Klf5 loss led to a reduced number of myeloid-derived cells, particularly granulocytic myeloid-derived suppressor cells (gMDSCs), but an augmented number of both CD4+ and CD8+ T cells in pancreatic cancer models 26. This evidence concerns the gene KLF5 and pancreatic neoplasm.